foxo4-dri peptide 2MG/5MG/10MG VIAL – UMBRELLA Labs FOXO4-DRI part 1 , #peptide

Therapeutic Research Protocol Dose: 200 400 mcg Duration: 6 8 weeks Frequency: Daily Cycle Interval: 8 weeks off before repeating Goal / Description: Extended protocol used in models targeting vascular aging and microcirculation

Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide

Failure to comply with the DPA and its obligations, including the breach of duties of disclosure or due diligence, can result in a fine of up to CHF 250,000 for the controller

Note: if using a 3ml/cc mixing syringe steps 2 - 6 will need to be completed several times to transfer all the fluid into the powder